NCT06694987

Brief Summary

This study is a substudy of the Strenghtening Community Roots (SCORE!) Cohort study. The investigators will look for people, enrolled in the SCORE! Cohort study, with abnormal results related to blood sugar and fat, as well as high blood pressure and heart disease risks. The investigaors will try to help the community improve sugar, fat and blood pressure through trained people who are not necessarily a medical doctor but have health-sciences-training backgrounds. These people are called Non-Physician Health Workers (NPHW), and they will be under the direction of a medical doctor and will be also in close communication with the participants and the medical doctor to improve their health. This will happen through a total of 12 months, having online and on-site visits, for follow-up.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
137

participants targeted

Target at P50-P75 for not_applicable hypertension

Timeline
43mo left

Started Nov 2024

Longer than P75 for not_applicable hypertension

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress29%
Nov 2024Dec 2029

First Submitted

Initial submission to the registry

October 11, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 19, 2024

Completed
1 day until next milestone

Study Start

First participant enrolled

November 20, 2024

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2028

Expected
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2029

Last Updated

November 19, 2024

Status Verified

November 1, 2024

Enrollment Period

4.1 years

First QC Date

October 11, 2024

Last Update Submit

November 15, 2024

Conditions

Keywords

CardiovascularHealthy active livingNewcomerNon-Physician Health Worker

Outcome Measures

Primary Outcomes (1)

  • Framinghman risk score (FRS)

    A change in Framingham Risk Score from baseline to 12 months. Values are estimated as risk percentages (the likelihood) to have a major adverse cardiovascular events (MACE) within the next 10 years. \< 10 % = Low risk 10-20 % = Intermediate risk \> 20 % = High risk

    12 months

Secondary Outcomes (14)

  • HbA1c

    12 months

  • HbA1c

    12 months

  • Blood pressure

    12 months

  • Blood pressure

    12 months

  • Lipid panel

    12 months

  • +9 more secondary outcomes

Study Arms (1)

Implementation group.

EXPERIMENTAL

The study is based on the HOPE-4 protocol, where trained individuals will support participants in adhering to healthy lifestyle recommendations and support their access to a family physician to follow up on care recommendations. The NPHWs will be allied health professionals (e.g., pharmacists, internationally trained physicians, physiotherapists, nurses). The team will train them on study goals, responsibilities, data management, and follow-up, based on the HOPE-4 training manual. Training will be given once at the beginning of their role and then once annually. The NPHW will support the participant, if needed, in contacting the family doctor and assisting to arrange a follow-up study. If required, the family doctor can contact the NPHW. If further discussion is required or there are questions regarding the study that require further discussion, the NPHW will contact the study physician to address these issues.

Other: Non-Physician Health Worker

Interventions

NPHW will aid participants in accessing a family doctor if required. The family doctor will receive a letter from the study, with suggested medication, based on the HOPE-4 algorithm. The family doctor may decide not to prescribe the recommended treatment or give another treatment (medication). In such case, the participant will still be part of the study and family physician's decision and reason why will be recorded. Follow-up will occur as per the visit schedule. All participants will attend a 20-minute follow-up visits in person at 0, 6 and 12 months, and via telephone at 3 and 9 months. Participants will be assessed to determine if: i. the patient was assessed by their family physician, ii. the family doctor initiated recommended medication treatment(s), iii. they are adhering to the medications as prescribed, iv. they implemented what the NPHW has recommended about dietary and lifestyle changes, using the specific, measurable, achivable, relevant, time-bound (SMART) for goals.

Implementation group.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Involvement in another study or program that would interfere with the study protocol,
  • Known history of coronary artery disease or stroke;
  • Severe co-morbid conditions with life expectancy \< 1 year,
  • Pregnancy or plans to become pregnant within 12 months;
  • Other serious conditions or logistic factors likely to interfere with study participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

McMaster University

Hamilton, Ontario, L8S 4L8, Canada

Location

Related Publications (1)

  • Schwalm JD, McCready T, Lopez-Jaramillo P, Yusoff K, Attaran A, Lamelas P, Camacho PA, Majid F, Bangdiwala SI, Thabane L, Islam S, McKee M, Yusuf S. A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial. Lancet. 2019 Oct 5;394(10205):1231-1242. doi: 10.1016/S0140-6736(19)31949-X. Epub 2019 Sep 2.

    PMID: 31488369BACKGROUND

MeSH Terms

Conditions

HypertensionDiabetes MellitusDyslipidemiasMetabolic Syndrome

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesLipid Metabolism DisordersInsulin ResistanceHyperinsulinism

Study Officials

  • Sonia Anand, MD, PhD

    McMaster University

    PRINCIPAL INVESTIGATOR
  • Lita Cameron, MD, MSc

    McMaster University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sonia Anand, PhD, MD

CONTACT

Dipika Desai, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: This is a quasi-experimental, one group, pre-post design study.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Vice-President, Global Health Department, Professor of Epidemiology, Vascular Medicine Specialist, Principal Investigator

Study Record Dates

First Submitted

October 11, 2024

First Posted

November 19, 2024

Study Start

November 20, 2024

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

December 1, 2029

Last Updated

November 19, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

We currently dont have plans for sharing IPD. If this changes in the future, the consent form explains as follow: The participant's personal, identifiable data will not be shared with anyone except with the participant's consent or as required by the laws of the province of Ontario. All information that could identify the participant, such as name and phone number, will only be accessible to the study members who need this information to contact the participant for study purposes (e.g., invite the participant to activities). Before the investigators analyze the data collected, all identifying information will be removed. The de-identified data will be retained until it no longer hold scientific value. If the participant previously consented to sharing of data with other researchers or to data repositories in the main cohort study, data from this study will also be shared. If the participant no longer wish for this to occur the investigators will be notified. HiREB # 17633

Locations